Lymphocyte and macrophage infiltration in omental metastases indicates poor prognosis in advance stage epithelial ovarian cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lymphocyte and macrophage infiltration in omental metastases indicates poor prognosis in advance stage epithelial ovarian cancer
Authors
Keywords
-
Journal
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
Volume 49, Issue 12, Pages 030006052110662
Publisher
SAGE Publications
Online
2021-12-23
DOI
10.1177/03000605211066245
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epithelial ovarian cancer
- (2019) Stephanie Lheureux et al. LANCET
- Tumor-Associated Macrophages (TAMs): A Critical Activator In Ovarian Cancer Metastasis
- (2019) Meichen Yin et al. OncoTargets and Therapy
- Who are the long-term survivors of high grade serous ovarian cancer?
- (2018) Claire Hoppenot et al. GYNECOLOGIC ONCOLOGY
- Tumor-associated macrophages and the tumor immune microenvironment of primary and recurrent epithelial ovarian cancer
- (2018) Laureen S. Ojalvo et al. HUMAN PATHOLOGY
- Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer
- (2018) Mauricio P. Pinto et al. GYNECOLOGIC ONCOLOGY
- The Tumor Microenvironment of Epithelial Ovarian Cancer and Its Influence on Response to Immunotherapy
- (2018) Galaxia Rodriguez et al. Cancers
- Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis
- (2017) Xia Yuan et al. GYNECOLOGIC ONCOLOGY
- Immunological Functions of the Omentum
- (2017) Selene Meza-Perez et al. TRENDS IN IMMUNOLOGY
- The prognostic value of tumor-infiltrating T lymphocytes in ovarian cancer
- (2017) Jun Li et al. Oncotarget
- Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients
- (2016) Bradley J. Monk et al. CURRENT PHARMACEUTICAL DESIGN
- Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
- (2016) Mingzhu Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- High Infiltration of Tumor-Associated Macrophages Influences Poor Prognosis in Human Gastric Cancer Patients, Associates With the Phenomenon of EMT
- (2016) Jia Zhang et al. MEDICINE
- Tumor infiltrating lymphocytes in ovarian cancer
- (2015) Phillip P Santoiemma et al. CANCER BIOLOGY & THERAPY
- Evaluation of in vitro chemoresponse profiles in women with Type I and Type II epithelial ovarian cancers: An observational study ancillary analysis
- (2015) Rebecca Previs et al. GYNECOLOGIC ONCOLOGY
- High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer
- (2015) Keijiro Sugimura et al. JOURNAL OF SURGICAL ONCOLOGY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
- (2014) Meiying Zhang et al. Journal of Ovarian Research
- Milky Spots Promote Ovarian Cancer Metastatic Colonization of Peritoneal Adipose in Experimental Models
- (2013) Robert Clark et al. AMERICAN JOURNAL OF PATHOLOGY
- Prognostic Significance of B-Cells and pSTAT3 in Patients with Ovarian Cancer
- (2013) Chunmei Yang et al. PLoS One
- Association of Intra-tumoral Infiltrating Macrophages and Regulatory T Cells Is an Independent Prognostic Factor in Gastric Cancer after Radical Resection
- (2011) Bo Wang et al. ANNALS OF SURGICAL ONCOLOGY
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma
- (2010) Martin Pölcher et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More